226P Impact of BMI on outcome and cardiac safety in HER2-positive breast cancer patients treated with adjuvant trastuzumab: Results of a monocentric observational study
- Resource Type
- Source
- Annals of Oncology. 31:S331
- Subject
Oncology medicine.medical_specialty business.industry medicine.medical_treatment Hematology Outcome (game theory) Trastuzumab Internal medicine HER2 Positive Breast Cancer medicine Observational study business Adjuvant medicine.drug - Language
- ISSN
- 0923-7534